Obecure Achieves Successful Results in Its Proof of Concept Clinical Study Evaluating the Ability of Histalean(TM) to Mitigate Weight Gain Associated With Olanzapine
6/15/2009 9:47:44 AM
More...
|
Obecure Completes Patient Enrollment for Its Confirmatory Phase IIb Trial with HistaleanTM in Obesity
1/20/2009 11:59:37 AM
More...
|
Obecure Recruits First Patient in Phase II Obesity Study in Pre-Menopause Women
9/8/2008 8:59:34 AM
More...
|
Obecure Signs Strategic Agreement with Farmaceutici-Formenti of the Grunenthal Group for Manufacturing and Supply of Betahistine in Europe
4/9/2008 8:23:26 AM
More...
|
Obecure Phase II Trial Shows Positive Results For Histalean(TM) In Obese Women Under 50
8/30/2007 7:38:00 AM
More...
|
Obecure Completes Treatment of Patients in Phase II Obesity Trial
6/25/2007 1:32:00 PM
More...
|
Obecure Initiates Phase II Study to Examine Effect of OBE101 on Plasma Lipids in Patients Treated With Simvastatin
5/16/2007 12:20:56 PM
More...
|
Obecure Completes Patient Enrollment for Phase II Obesity Trial
4/11/2007 12:35:51 PM
More...
|
Obecure Initiates Phase II Weight Gain Prevention Study for Patients Taking Zyprexa
3/13/2007 1:24:37 PM
More...
|
Obecure Recruits First Patient In Phase II Obesity Study
1/24/2007 11:33:48 AM
More...
|